A bill that targets pay-to-delay settlements between brand name and generic drug manufacturers has been a hot topic around the nation this week. Also this week:
- A look at the Congressional track record with regard to controlling health care costs.
- Industry asks for the medical loss ratio rules to be abolished while other’s are applying for exemption waivers.
- CMS is recruiting seniors to help tackle fraud.